Ricardo et al. [11] analyzed the expression of CD44/CD24 and ALDH1 in a panel of 466 invasive breast carcinomas, finding that basal-like tumors (76.5%) contained the highest percentage of cells with the CSC phenotype CD44+CD24−/low. Here, CD44 is linked to invasive breast carcinoma.